Another group of antidepressant are dual NET/DAT inhibitors (e.g., nomifensin), while triple reuptake inhibitors (SERT/DAT/NET inhibitors, e.g., indatraline and mazindol) are being examined for their efficacy in depression and other CNS-disorders [158]. Here, SLC6A2 is linked to central nervous system disorder.